Prognostic models in chronic liver disease: Validity, usefulness and future role

Journal of Hepatology

Volumn 26, Issue 6, 1997, Pages 1414-1424

  Christensen, Erik ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER DISEASE; CHRONIC LIVER DISEASE; DISEASE SEVERITY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; REVIEW;

EID: 0030740096     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80481-3     Document Type: Review

References (57)

1. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 35:1977;1-39.
2. Christensen E. Individual therapy-dependent prognosis based on data from controlled clinical trials in chronic liver disease (thesis). Dan Med Bull. 35:1988;167-182.
3. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. CSL. A therapeutic index that predicts the individual effect of prednisone in patients with cirrhosis. Gastroenterology. 88:1985;165-165.
4. Armitage P, Berry G. 3rd Edn. Statistical Methods in Medical Research. 1994;Blackwell, Oxford.
5. Cox DR. Regression models and life tables (with discussion). J R Statist Soc B. 34:1972;187-220.
6. Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology. 7:1987;1346-1358.
7. Child CG, Turcotte JG. Surgery and portal hypertension. Child CG. The Liver and Portal Hypertension. 1964;50 W.B. Saunders Co. Philadelphia.
8. Conn HO. A peek at the Child-Turcotte classification. Hepatology. 1:1981;673-676.
9. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
10. Christensen E, Schlichtinmg P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, Tygstrup N. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology. 4:1984;430-435.
11. Villaneuve JP, Infante-Rivard C, Ampelas M, Pomier-Layargues G, Huet PM, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology. 6:1986;928-931.
12. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, Juhl E, Poulsen H, Tygstrup N. CSL. Updating prognosis and the therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol. 21:1986;163-174.
13. Christensen E, Kriñtel JJ, Meltofte Hansen S, Krogh Johanse J, Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Scand J Gastroenterol. 24:1989;999-1006.
14. Abad Lacruz A, Cabre E, Gonzalez Huix F, Fernandez Banares F, Esteve M, Planas R, Llovet JM, Quer JC, Gassull MA. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol. 88:1993;382-387.
15. Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology. 3:1983;889-895.
16. D'Amico G, Morabito A, Pagliaro L, Marubini ETI. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 31:1986;468-475.
17. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, Caballeria J, Rodes J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 7:1987;122-128.
18. Merli M, Riggio O, Dally L, Capocaccia L, Lionetti R, De Luca M, Guardascione MA, Surrenti M, Marra F, Gentilini P, Nardone G, Budillon G, Loguercio C, Blanco CDV, Collorti M, Guglielmi W, Francavilla A. Does malnutrition affect survival in cirrhosis? Hepatology. 23:1996;1041-1046.
19. Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, Angeli P, Gatta A. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut. 33:1992;836-842.
20. Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, Iervese T, Marchesini G, Ruol A. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci. 36:1991;1197-1203.
21. Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ. Plasma catecholamine level and portal vanous pressure as guides to prognosis in patients with cirrhosis. J Hepatol. 6:1988;350-358.
22. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, Sacerdoti D, Angeli P, Gatta A. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 102:1992;973-979.
23. Finucci G, Bellon S, Merkel C, Mormino P, Tirelli M, Gatta A, Zuin R. Evaluation of splanchnic angiography as a prognostic index of survival in patients with cirrhosis. Scand J Gastroenterol. 26:1991;951-960.
24. Orrego H, Israel Y, Blake JE, et al. Assessment of prognostic factors in alcoholic liver disease: Toward a global quantitative expression of severity. Hepatology. 3:1983;896-905.
25. Tygstrup N, Andersen PK, Thomsen BLR. Prognostic evaluation in alcoholic cirrhosis. Acta Med Scand. 703:1985;149-156. Suppl.
26. Pignon JP, Poynard T, Naveau S, Marteau P, Zourabichvili O, Chaput JC. Multidimensional analysis by Cox's model of the survival of patients with alcoholic cirrhosis. Gastroenterol Clin Biol. 10:1986;461-467.
27. Keiding S, Badsberg JH, Becker U, Bentsen KD, Bonnevie O, Caballeria J, Eriksen J, Hardt F, Keiding N, Morgan M, Poulsen H, Ranek L, Rodes J, Schou G, Walker R, Tygstrup N. The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malothilate on survival. J Hepatol. 20:1994;454-460.
28. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A. Natural history and prognostic factors for chronic hepatitis type B. Gut. 32:1991;294-298.
29. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology. 103:1992;1630-1635.
30. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, Giustina G, Noventa F. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol. 21:1994;656-666.
31. Fattowich G, Giustina G, Degos F, Tremolada F, Diodati P, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas HC, Niapoum C, Bonetti P, Casarin C, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G. Survival and prognostic indicators in cryptogenic compensated cirrhosis: a multicenter study. (abstract) J Hepatol. 23:1995;122. suppl. 1.
32. Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, Tygstrup N, Williams R. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology. 78:1980;236-246.
33. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 89:1985;1084-1091.
34. Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, Glick KA, Eagen KA. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med. 315:1986;1448-1454.
35. Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, Ring-Larsen H, Rodes J, Navasa M, Trepo C, Pape G, Schou G, Badsbad JH, Andersen PK. Cyclosporin A treatmen in primary biliary cirrhosis. Results of a long-term placebo controlled trial. Gastroenterology. 104:1993;519-526.
36. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 110:1996;1515-1518.
37. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 20:1979;137-140.
38. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 308:1983;1-7.
39. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: a model for decision making. Hepatology. 10:1989;1-7.
40. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, MacSween RNM, Watkinson G. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 84:1989;713-716.
41. Rydning A, Schrumpf E, Abdelnoor M, Elgio K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol. 25:1990;119-126.
42. Biagini MR, Guardascione M, Raskino C, McIntyre N, Surrenti C, Burroughs AK. Poor prognostication for survival of individual PBC patients with Cox models. J Hepatol. 11:1990;S7. (Suppl 2).
43. Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. PBC1 and PBC2 trial groups. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterlogy. 105:1993;1865-1876.
44. Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patients visit. Hepatology. 20:1994;126-134.
45. Hughes MD, Raskino CL, Pocock SJ, Biagini MR, Burroughs AK. Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med. 11:1992;1731-1745.
46. Neuberger J, Altman DG, Christensen E, Tygstrup N, Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation. 41:1986;713-716.
47. Markus B, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GBG, Wiesner RH, Van Thiel DH, Starzl TE. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med. 320:1989;1709-1713.
48. Bonsel GJ, Klompmaker IJ, van't Veer F, Habbema JD, Slooff MJ. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet. 335:1990;493-497.
49. Neuberger J, Altman DG, Polson R, Buckels J, Rolles K, Elias E, Calne R, McMaster P, Williams R. Prognosis after liver transplantation for primary biliary cirrhosis. Transplantation. 48:1989;444-447.
50. Wiesner RH, Grambsch PM, Dickson E, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 10:1989;430-436.
51. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 100:1991;1710-1717.
52. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, La Russo NF, Malinchoc M, Chapman RW, Kaplan MM, Madrey WC, Williams R, Farrant M, Langworthy A. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology. 103:1992;1136-1142.
53. Broome U, Olofsson L, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. (abstract) J Hepatol. 23:1995;166. Suppl 1.
54. Broome U, Eriksson LS. Assessment for liver transplantation in patient with primary sclerosing cholangitis. J Hepatol. 20:1994;654-659.
55. Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. CSL. Changes of laboratory variables with time in cirrhosis. Prognostic and therapeutic significance. Hepatology. 5:1985;843-853.
56. Christensen E, Schunck MR. Scores in different diseases: a critical view and evaluation of different surrogate markers for assessing treatments in chronic liver disease. Poupon RE, Reichen J. Surrogate markers to assess efficacy of treatments in chronic liver disease. 1996;46-59 Kluwer, London.
57. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone. N Engl J Med. 291:1974;271-273.